Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF- Κ B Inhibition
Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.116.239608
Full Text
Open PDFAbstract
Available in full text
Date
April 27, 2017
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)